\nMedicii de la National Institute for Health and Care Excellence din Marea Britanie spun c\u0103 Pembrolizumab este un medicament eficient pentru pacien\u0163ii care l-au testat \u015fi care nu au urmat un tratament cu un alt produs, denumit Ipilimumab.<\/p>\n
\nPembrolizumab (Keytruda) a fost deja testat \u00een cadrul unei proceduri de aprobare accelerat\u0103, \u00een Marea Britanie, prin intermediul unui program guvernamental – Early Access to Medicines Scheme.<\/p>\n
\nTestele au dovedit c\u0103 Pembrolizumab poate s\u0103 opreasc\u0103 evolu\u0163ia tumorilor \u015fi chiar s\u0103 le mic\u015foreze.<\/p>\n
\nMelanomul, cea mai grav\u0103 form\u0103 a cancerului de piele, ocup\u0103 locul al cincilea \u00een topul celor mai frecvente tipuri de cancer din Marea Britanie. Boala face peste 2.000 de victime \u00een aceast\u0103 \u0163ar\u0103, \u00een fiecare an.<\/p>\n
\nPembrolizumab poate fi administrat prin perfuzie, o dat\u0103 la trei s\u0103pt\u0103m\u00e2ni, pentru a stopa procesul de formare a unor noi tumori \u00een stadiu avansat.<\/p>\n
\nPembrolizumab este considerat un “medicament din genera\u0163ia viitoare”, deoarece stimuleaz\u0103 sistemul imunitar al pacientului, f\u0103c\u00e2ndu-l s\u0103 lupte eficient \u00eempotriva bolii.<\/p>\n
\nMedicamentul este un anticorp monoclonal \u015fi blocheaz\u0103 un proces biologic pe care cancerul \u00eel utilizeaz\u0103 pentru a se “deghiza” \u015fi pentru a evita astfel atacurile lansate de sistemul imunitar.<\/p>\n
\nNoul tratament nu este ieftin – cost\u0103 aproximativ 3.000 de lire sterline per doz\u0103 -, \u00eens\u0103 produc\u0103torul s\u0103u, compania Merck Sharp and Dohme, a acceptat s\u0103 acorde Sistemului na\u0163ional de s\u0103n\u0103tate din Marea Britanie (NHS) o reducere de pre\u0163 substan\u0163ial\u0103.<\/p>\n","protected":false},"excerpt":{"rendered":"
Pembrolizumab, un medicament eficient \u00eempotriva cancerului de piele \u00een stadii avansate, va fi disponibil \u00een cur\u00e2nd \u00een Sistemul na\u0163ional de s\u0103n\u0103tate (NHS) din Marea Britanie, \u00een urma unei proceduri de aprobare accelerat\u0103, informeaz\u0103 bbc.com.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[41769,41768],"class_list":["post-127940","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-cancer-de-piele","tag-pembrolizumab"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/127940","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=127940"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/127940\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=127940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=127940"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=127940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}